TGF-beta-1/GARP inhibitor (Scholar Rock/Janssen Biotech)

N/A

Report date: 2025/03/19 18:26:20

Base Information

Drug NameTGF-beta-1/GARP inhibitor (Scholar Rock/Janssen Biotech)
Drug Alias NameTreg modulator (Scholar Rock/Janssen Biotech)anti-TGFB1-GARP complex antibodies (Scholar Rock/Janssen Biotech)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTransforming growth factor beta 1 inhibitorsTransforming growth factor beta activator LRRC32 inhibitors
TargetsTransforming growth factor beta activator LRRC32Transforming growth factor beta 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesScholar Rock Inc
China Registration ClassN/A

Develop Information

Active CompaniesScholar Rock IncJanssen Biotech Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A